{"id":192638,"name":"THE BIOSIMILARS FORUM","slug":"the-biosimilars-forum","state":"DC","description":"Non-profit Organization","totalSpending":2280000,"filings":24,"yearlySpending":[{"year":2019,"income":180000},{"year":2020,"income":360000},{"year":2021,"income":270000},{"year":2022,"income":270000},{"year":2023,"income":400000},{"year":2024,"income":400000},{"year":2025,"income":400000}],"firms":["THORN RUN PARTNERS"],"lobbyists":["ALEX DELPIZZO","STUART CHAPMAN","JESSIE BRAIRTON","THAYER ROBERTS"],"issues":["PHA","MED","ACC","HCR","MMM",null],"sampleDescriptions":["Medicare reimbursement issues; FDA regulations of biosimilars.","Medicare reimbursement issues. FDA regulations of biosimilars.","Drug pricing legislation. HR 1520, Purple Book Continuity Act of 2019.","Drug pricing legislation. \nH.R. 1520, Purple Book Continuity Act of 2019. \nS. 2543, Prescription Drug Pricing Reduction Act of 2019. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.","Medicare reimbursement issues. FDA regulations of biosimilars. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.","Drug pricing legislation. \nH.R. 1520, Purple Book Continuity Act of 2019. \nS. 2543, Prescription Drug Pricing Reduction Act of 2019. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.","Medicare reimbursement issues. FDA regulations of biosimilars. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.","Medicare reimbursement issues. FDA regulations of biosimilars. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.\nS. 4134, A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program.","Drug pricing legislation. \nS. 2543, Prescription Drug Pricing Reduction Act of 2019. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.\nS. 4134, A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program.","Drug pricing legislation. \nS. 2543, Prescription Drug Pricing Reduction Act of 2019. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.\nS. 4134, A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program. \nThe Cares Act (P.L. 116-136).\nH.R. 925, HEROES Act.","Medicare reimbursement issues. FDA regulations of biosimilars. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.\nS. 4134, A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program. \nThe Cares Act (P.L. 116-136).\nH.R. 925, HEROES Act.","Drug pricing legislation. \nS. 2543, Prescription Drug Pricing Reduction Act of 2019. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.\nS. 4134, A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program. \nH.R. 133, Consolidating Appropriations Act, 2021.\nH.R. 925, HEROES Act.","Medicare reimbursement issues. FDA regulations of biosimilars. \nH.R. 4597, Acting to Cancel Copays and Ensure Substantial Savings for Biosimilars Act of 2019.\nH.R. 4455, BIOSIM Act.\nH.R. 4629, Star Rating for Biosimilars Act.\nS. 1895, Lower Health Care Costs Act.\nS. 3466, ACCESS for Biosimilars Act of 2020.\nH.R. 6179, Increasing Access to Biosimilars Act of 2020.\nS. 4134, A bill to establish a demonstration project to increase access to biosimilar products under the Medicare program. \nH.R. 133, Consolidating Appropriations Act, 2021.\nH.R. 925, HEROES Act.","Medicare reimbursement issues. FDA regulations of biosimilars.\nIssues related to Drug Pricing Reduction and increasing access to Biosimilars. \nS. 164, Advancing Education on Biosimilars Act of 2021. \nDepartments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022.\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act\nH.R. 2815, BIOSIM Act\nH.R. 2855, Star Rating for Biosimilars Act. \nH.R. 2868, Protecting Access to Affordable Medicines Act of 2021\nH.R. 2869, Increasing Access to Biosimilars Act of 2021.\nS. 1427, Increasing Access to Biosimilars Act of 2021.","Drug pricing legislation.\nIssues related to Drug Pricing Reduction and increasing access to Biosimilars. \nS. 164, Advancing Education on Biosimilars Act of 2021. \nDepartments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022.\nH.R. 3, Elijah E. Cummings Lower Drug Costs Now Act\nH.R. 2815, BIOSIM Act\nH.R. 2855, Star Rating for Biosimilars Act. \nH.R. 2868, Protecting Access to Affordable Medicines Act of 2021\nH.R. 2869, Increasing Access to Biosimilars Act of 2021.\nS. 1427, Increasing Access to Biosimilars Act of 2021.","Drug pricing legislation.\nIssues related to Drug Pricing Reduction and increasing access to Biosimilars. \nDepartments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022.\nH.R. 2815, BIOSIM Act\nH.R. 2855, Star Rating for Biosimilars Act. \nH.R. 2869, Increasing Access to Biosimilars Act of 2021.\nS. 1427, Increasing Access to Biosimilars Act of 2021. \nBuild Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.","Medicare reimbursement issues. FDA regulations of biosimilars.\nIssues related to Drug Pricing Reduction and increasing access to Biosimilars.  \nDepartments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022\nH.R. 2815, BIOSIM Act\nH.R. 2855, Star Rating for Biosimilars Act. \nH.R. 2869, Increasing Access to Biosimilars Act of 2021.\nS. 1427, Increasing Access to Biosimilars Act of 2021.\nBuild Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.","Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R. 4502, Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2022 H.R. 2815, BIOSIM Act H.R. 2855, Star Rating for Biosimilars Act. H.R. 2869, Increasing Access to Biosimilars Act of 2021. S. 1427, Increasing Access to Biosimilars Act of 2021. Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.","Drug pricing legislation. H.R. 4502, Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R. 4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2022. H.R. 2815, BIOSIM Act H.R. 2855, Star Rating for Biosimilars Act. H.R. 2869, Increasing Access to Biosimilars Act of 2021. S. 1427, Increasing Access to Biosimilars Act of 2021. Build Back Better: S. Con. Res. 14, A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031. Efforts surrounding user fees. H.R. 7006, the Improving the Nations Safe Pharmaceuticals and Excipients by Creating Tools for Inspecting and Overseeing Needed Supplies Act or the INSPECTIONS Actï»¿","Medicare reimbursement issues. FDA regulations of biosimilars. Issues related to Drug Pricing Reduction and increasing access to Biosimilars. H.R.4502 - Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2022. H.R.2815 - BIOSIM Act. H.R.2855 - Star Rating for Biosimilars Act. H.R.2869 - Increasing Access to Biosimilars Act of 2021. S.1427 - Increasing Access to Biosimilars Act of 2021. H.R.5376 - Inflation Reduction Act of 2022"],"years":[2019,2020,2021,2022,2023,2024,2025]}